(Q53287201)
Statements
A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. (English)
Christopher H van Dyck
Pierre N Tariot
Barnett Meyers
E Malca Resnick
Memantine MEM-MD-01 Study Group
1 April 2007
21
2
136-143